ALNYLAM PHARMACEUTICALS INC's ticker is and the CUSIP is 02043Q957. A total of 5 filers reported holding ALNYLAM PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $921,000 | -3.5% | 16,600 | +9.2% | 0.00% | 0.0% |
| Q1 2016 | $954,000 | -32.0% | 15,200 | +2.0% | 0.00% | -50.0% |
| Q4 2015 | $1,403,000 | -49.7% | 14,900 | -57.1% | 0.00% | -33.3% |
| Q3 2015 | $2,788,000 | -56.9% | 34,700 | -35.7% | 0.00% | -50.0% |
| Q2 2015 | $6,473,000 | +123.8% | 54,000 | +94.9% | 0.01% | +100.0% |
| Q1 2015 | $2,892,000 | +102.8% | 27,700 | +88.4% | 0.00% | +200.0% |
| Q4 2014 | $1,426,000 | +67.6% | 14,700 | +34.9% | 0.00% | 0.0% |
| Q3 2014 | $851,000 | +10.4% | 10,900 | -10.7% | 0.00% | 0.0% |
| Q2 2014 | $771,000 | -35.9% | 12,200 | -31.8% | 0.00% | 0.0% |
| Q1 2014 | $1,202,000 | +83.2% | 17,900 | +75.5% | 0.00% | 0.0% |
| Q4 2013 | $656,000 | -33.9% | 10,200 | -34.2% | 0.00% | -50.0% |
| Q3 2013 | $992,000 | +46.7% | 15,500 | -28.9% | 0.00% | +100.0% |
| Q2 2013 | $676,000 | – | 21,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 50,000 | $7,293,000 | 0.42% |
| GROUP ONE TRADING, L.P. | 160,100 | $23,351,000 | 0.04% |
| JANE STREET GROUP, LLC | 271,600 | $39,613,000 | 0.02% |
| SIMPLEX TRADING, LLC | 20,600 | $3,004,000 | 0.00% |
| Twin Tree Management, LP | 3,600 | $525,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 11,900 | $1,736,000 | 0.00% |